New potential markers for cartilage degradation of the knee joint

Scandinavian Journal of Rheumatology

Volumn 31, Issue 3, 2002, Pages 151-157

  Schmidt Rohlfing, Bernhard ^a   Gavenis, Karsten ^a   Kippels, Martin ^a   Schneider, Ulrich ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Biochemical markers; Cartilage degradation; Correlation; Synovial fluid

Indexed keywords

BIOCHEMICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGENASE 3; GLYCOPROTEIN GP 39; INTERSTITIAL COLLAGENASE; STROMELYSIN; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CARTILAGE DEGENERATION; CLINICAL TRIAL; CORRELATION COEFFICIENT; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; STAGING; SYNOVIAL FLUID;

EID: 0036296317     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/rhe.31.3.151.157     Document Type: Article

References (37)

1. Synovial fluid markers in osteoarthritis
2. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
3. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not in synoviocytes: A role in osteoarthritis
4. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid
5. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: A cross sectional study
6. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling
7. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis
8. Cartilage metabolism in the injured and uninjured knee of the same patient
9. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury
10. The etiology of chondromalacia patellae
11. A system for grading articular cartilage lesions at arthroscopy
12. Development of criteria for the classification and reporting of osteoarthritis of the knee
13. Indices of severity for osteoarthritis of the hip and the knee. Validation - Value in comparison with other assessment tests
14. Validation of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or the knee
15. WOMAC osteoarthritis index. Reliability, validity, and responsiveness in patients with arthroscopically assessed osteoarthritis
16. Radiological assessment of osteoarthritis
17. Arthroscopic evaluation of knee articular cartilage
18. Increased levels of proteoglycan fragments in knee joint fluid after injury
19. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella
20. Tenascin is associated with chondrogenic and osteogenic differentiation in vivio and promotes chondrogenesis in vitro
21. Tenascin-C in the pathophysiology and healing process of musculoskeletal tissue injury
22. Tenascin is increased in cartilage and synovium from arthritic knees
23. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues
24. Mechanical loading regulates tenascin-c expression in the osteotendineous junction
25. Matrix metalloproteinases: Structures, evolution, and diversification
26. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
27. Cloning of collagenase-3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis
28. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury
29. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: Comparison with generalized osteoarthritis
30. Relationship of matrix metalloproteinases and their inhibitor to cartilage proteoglycan and collagen turnover
31. Small fragments of oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation
32. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
33. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint
34. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity
35. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage
36. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint
37. The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis